Francesca Celesti
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Multidisciplinary characterization of rare MPL Y591 and R592 variants in myeloid disorders: from clinical correlation and literature-based evidence to in silico predictors and structural bioinformatics.
Journal: Experimental hematology
Published: March 24, 2026
Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.
Journal: Mediterranean journal of hematology and infectious diseases
Published: February 06, 2025
Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment.
Journal: Leukemia & lymphoma
Published: September 12, 2023
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Journal: Annals of hematology
Published: April 16, 2019
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.
Journal: British journal of haematology
Published: February 08, 2017
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
Journal: Annals of hematology
Published: September 25, 2016
Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients.
Journal: Leukemia research
Published: April 11, 2015
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival.
Journal: Leukemia research
Published: April 12, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026